NYSE · WRBY

Warby Parker Inc.

$24.86 +$0.30 (+1.22%) 1D Pre-market

Key Metrics

$3.01B
Market cap
2,239.14×
P/E · TTM
$890.57M
Revenue · TTM
$1.35M
Net income
EPS · TTM $0.01
Dividend yield
Free cash flow $38.90M
Beta · 1Y 2.11
EBITDA · TTM $54.00M
Gross margin 53.4%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved +23.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Apr 2
    From its Mar 3 high, the share price fell 26%.

    Peak close $27.48 on Mar 3; trough close $20.29 on Apr 2. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -26%
  • Feb 26
    The stock moved +17.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 26

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$3.01B
Enterprise value
Shares outstanding122.7M
52-wk range$14.96 – $31.00
Avg volume · 20D1.8M
Net cash
Book value / share$3.02
IndustryOphthalmic Goods
ExchangeNYSE
About Warby Parker Inc.
IPO dateSep 29, 2021
Employees4036

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E2,239.14
P/S3.38
P/FCF77.47
EV/EBITDA
EV/Sales
Graham №$0.86

Profitability

Gross 53.4%
Operating 0.2%
Net 0.2%
FCF 4.4%
ROE / ROIC 0.4% · 1.5%

Financial Health

Current ratio2.33
Quick ratio2.03
Debt / equity
Debt / EBITDA
Net cash
Working capital$204.41M

Cash Flow · TTM

Operating CF $105.94M
Capex −$67.03M
Free cash flow $38.90M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

5.3
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$0.86 vs $24.86
Trades 29.0× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings